Development of novel epoxyketone macrocyclic peptidyl proteasome inhibitors through OPA-mediated one-step cyclization of unprotected peptides.
Zeng G, Xu G, Gao L, Zheng X, Chi X, Shen Z, Cao Y, Xi J, Che J, Dong X, Shi Y, Ma J, Zhang C, Zeng L, Zhu H, Shao J, Zhou Y, Li J, Zhang J.
Zeng G, et al.
Bioorg Chem. 2025 Jan 18;156:108180. doi: 10.1016/j.bioorg.2025.108180. Online ahead of print.
Bioorg Chem. 2025.
PMID: 39855110